| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.91M | 23.90M | 24.75M | 25.36M | 25.03M | 20.94M |
| Gross Profit | 6.65M | 23.90M | -2.23M | -1.88M | 1.01M | 211.00K |
| EBITDA | 1.93M | 1.37M | 2.92M | 4.10M | 7.73M | 2.94M |
| Net Income | -6.57M | -6.57M | -4.67M | -4.24M | -1.62M | -4.12M |
Balance Sheet | ||||||
| Total Assets | 60.99M | 60.99M | 53.05M | 45.83M | 44.67M | 46.23M |
| Cash, Cash Equivalents and Short-Term Investments | 3.88M | 3.88M | 8.31M | 9.83M | 14.14M | 16.55M |
| Total Debt | 33.66M | 33.66M | 20.31M | 3.86M | 2.92M | 3.64M |
| Total Liabilities | 43.15M | 43.15M | 28.53M | 16.83M | 11.67M | 11.53M |
| Stockholders Equity | 17.84M | 17.84M | 24.52M | 29.00M | 33.00M | 34.33M |
Cash Flow | ||||||
| Free Cash Flow | 1.51M | -2.11M | -1.35M | -4.78M | -3.81M | -5.37M |
| Operating Cash Flow | 2.28M | 2.28M | 6.24M | 4.02M | 4.99M | 5.08M |
| Investing Cash Flow | -3.28M | -3.28M | -7.59M | -8.80M | -3.63M | -10.45M |
| Financing Cash Flow | -3.43M | -3.43M | -166.00K | 462.00K | -3.76M | -321.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$25.65M | -3.97 | -31.01% | ― | -3.43% | -40.65% | |
42 Neutral | AU$83.17M | -6.00 | -70.54% | ― | 9.67% | 31.03% | |
41 Neutral | AU$10.33M | -1.70 | -133.07% | ― | -4.90% | -52.78% | |
38 Underperform | AU$25.53M | -5.68 | -135.50% | ― | -48.98% | -12.82% |
Aerometrex Limited announced a correction to a previously lodged Appendix 3Y for Director Robert Veitch, clarifying the closing balance of shares held. The update does not alter any other details of the form, and the Board of Directors has approved the release. This correction ensures transparency in the company’s reporting of director interests, maintaining trust with stakeholders and compliance with ASX regulations.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Ltd. announced the issuance of 1,691,042 unquoted CEO Performance Rights as part of a previously announced transaction. This move reflects the company’s strategic initiatives to align executive incentives with performance goals, potentially impacting its operational dynamics and stakeholder interests.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Limited has announced a proposed issue of 1,691,042 securities under the ASX code AMX, scheduled for December 4, 2025. This issuance, categorized as CEO Performance Rights, is part of a strategic move to align executive compensation with company performance, potentially impacting the company’s market position and stakeholder interests.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Limited announced the results of its 2025 Annual General Meeting, where all resolutions were carried. The resolutions included the adoption of the remuneration report, re-election of a director, approval of an employee incentive securities plan, a salary sacrifice plan, and the issuance of performance rights to the CEO. These outcomes reflect shareholder support for the company’s strategic initiatives and governance practices.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Ltd. held its Annual General Meeting on November 25, 2025. The presentation provided during the meeting was intended for informational purposes only and did not serve as an offer or financial advice. It emphasized that the information contained might not be comprehensive for evaluating the company’s assets or making investment decisions. The company highlighted the presence of forward-looking statements, which are subject to uncertainties and risks that could lead to different actual outcomes.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Limited’s 2025 Annual General Meeting highlighted a year of strategic focus aimed at strengthening core businesses and achieving sustainable growth. The company reported significant growth in its MetroMap subscription base, reaching an Annual Contract Value of $11.54 million, surpassing the breakeven point. Despite challenges, Aerometrex maintained its market position in LiDAR and achieved strong growth in its 3D division. The company delivered an operating revenue of $23.90 million, with a notable increase in EBITDA by 19.7% to $3.46 million, driven by cost optimization and operational improvements. The strategic review conducted aims to enhance efficiency and explore corporate transactions for better shareholder value, while leadership changes have been implemented to support future growth.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Limited has announced a significant update to its MetroMap Mapviewer platform, introducing major new features such as Oblique Imagery and an Elevation tool, alongside a modernized user interface. The update aims to enhance user experience and broaden the platform’s appeal, supporting increased revenue per subscriber. The company has also restructured its sales team to drive growth and enterprise adoption, while expanding its MetroMap Capture program to cover 94% of the population. This strategic development positions MetroMap for sustained growth and differentiation in the market.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Ltd has announced its Annual General Meeting (AGM) scheduled for November 25, 2025, at its headquarters in Glynde, South Australia. The meeting will provide shareholders with the opportunity to assess and vote on various resolutions, with proxy voting options available for those unable to attend. This AGM is a significant event for stakeholders as it will influence the company’s future direction and governance.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Ltd. presented at the Australian Shareholders’ Association, emphasizing that the information shared is for informational purposes and not an investment advisory. The presentation highlighted the inherent risks and uncertainties in forward-looking statements, urging stakeholders to consider independent advice before making investment decisions. The company did not provide guarantees on future performance or returns, reflecting the volatile nature of the industry.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.
Aerometrex Limited reported a strong first quarter for 2026, showcasing significant growth across its product lines. The MetroMap service achieved an annualized growth rate of 42.75% in its Annual Contract Value, driven by large government contracts, positioning the company towards breakeven for the program. Additionally, a major 3D project win in the US has bolstered its international reputation and revenue prospects. LiDAR revenue also saw a 52% increase compared to the previous year, contributing to the company’s maintained cash position of $3.84 million. These developments reflect the company’s strategic execution and potential for sustainable growth, supporting long-term shareholder value.
The most recent analyst rating on (AU:AMX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Aerometrex Ltd. stock, see the AU:AMX Stock Forecast page.